ZAQS.ORG

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

10 hours ago

Eli Lilly's obesity pill eases sleep apnea in late-stage trial

10 hours ago

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

1 day ago

Jim Cramer says the AI trade is not going away as Nasdaq enters correction

5 days ago

CVS Health plans to split itself up. Here's why a breakup could make sense now

5 days ago

Jim Cramer says this bank stock is a buy after its post-election pullback

6 days ago

CVS falls on plans to split off drugstore business in major breakup

5 days ago

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

6 days ago

Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO

6 days ago

Midterm elections could jolt stocks as Democrats look poised to sweep Congress

6 days ago

A biotech's high-stakes cancer bet just paid off and its shares doubled

7 days ago

Jim Cramer says lower oil prices are giving stocks a boost. Can it last?

7 days ago

Stocks started the week higher but ended in despair. Our take on the big reversal

7 days ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

10 days ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

11 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

11 days ago

West Pharma: More than a GLP-1 play. The case for further upside

11 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

12 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

12 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

12 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

12 days ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

14 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

14 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

15 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

17 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

18 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

19 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

19 days ago

Sickle cell gene therapies offer new hope, but access remains a major challenge

25 days ago

Here's our monthly update on our 32 stocks, including 2 more names to buy

25 days ago

Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time

25 days ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

27 days ago